This does not assist the "non-fatal decompensated heart failure events" but instead:
“The trial results show that rexlemestrocel-L significantly reduces cardiovascular mortality when used early in heart failure patients at risk of disease progression"
Holy crap we just hit the big time, so (REVASCOR®) doesn't assist people that are not going die, instead, it stops heart failure mortality by 60% in people who would otherwise die!!! This is HUGE news, what is the market for heart failure, it is the leading cause of death, which MSB can halt by 60%...
who knows what this share price will get to once the market digests this news but certainly hold on...
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Phase 3 Chronic Heart Failure Results
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-82
-
- There are more pages in this discussion • 941 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.005(0.50%) |
Mkt cap ! $1.147B |
Open | High | Low | Value | Volume |
$1.02 | $1.02 | $1.00 | $1.187M | 1.176M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 148976 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 40528 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 151052 | 1.010 |
16 | 102452 | 1.005 |
15 | 142729 | 1.000 |
9 | 211867 | 0.995 |
10 | 573404 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.015 | 6719 | 8 |
1.020 | 227478 | 21 |
1.025 | 128608 | 10 |
1.030 | 76500 | 7 |
1.035 | 78950 | 4 |
Last trade - 13.37pm 19/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |